Welcome to our dedicated page for Nano-X Imaging news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging stock.
NANO-X IMAGING LTD reports news on an integrated medical imaging and healthcare services platform built around Nanox.ARC multisource digital tomosynthesis systems, AI and software solutions, cloud-based workflow tools, remote radiology access, health information technology and a marketplace model. Company updates commonly cover U.S. commercialization, distribution agreements, clinical collaborations and regulatory clearances tied to Nanox.ARC and related imaging capabilities.
Recurring financial and operating news also includes results from teleradiology services, imaging products and services, AI and software activity, and the completed addition of Nanox Health IT. The company frames its commercial activity around broader access to 3D imaging and preventive-care workflows across clinical settings.
NANO-X IMAGING LTD (NASDAQ: NNOX) reported its Q3 2021 results, ending the period with cash and marketable securities of $180.3 million. The company experienced a net loss of $13.5 million, up from $11.1 million in Q3 2020, primarily due to increased R&D and administrative expenses. Highlights include the completion of the Nanox AI merger and acquisitions of USARAD Holdings and MDWEB, aimed at enhancing its imaging technology and analytics capabilities. The company has signed MSaaS agreements for 6,500 Nanox.ARC units and expects to commercialize its technology in 2022.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced its participation in the 2021 Radiology Society of North America (RSNA) Annual Meeting from Nov. 28 to Dec. 2. Key highlights include the debut of the Nanox.ARC procedures at their virtual booth and a showcase of AI-enabled medical imaging solutions at booth 4949. A virtual tour from Shamir Medical Center will occur on Dec. 1 at 10:30 am CST. These advancements aim to enhance affordability and accessibility in medical imaging, aligning with their goal of improving early detection services.
NANO-X IMAGING LTD (NASDAQ: NNOX) has completed its merger with Zebra Medical Vision, Ltd., valued at approximately $110 million, with additional stock options worth up to $84 million contingent on performance milestones. The Company also acquired MDWEB, LLC and USARAD Holdings, Inc. for around $20 million in stock and cash, with potential additional payments of $10 million. These strategic acquisitions aim to enhance Nanox's AI-powered imaging solutions, addressing the global shortage of radiologists and improving healthcare delivery.
NANO-X IMAGING LTD (NNOX) is set to report its third-quarter results for the period ending September 30, 2021, on November 17, 2021, before market opening. Ran Poliakine, the CEO, along with Erez Meltzer, the newly appointed CEO effective January 1, 2022, will lead a conference call at 8:30 a.m. ET to discuss the results and provide a business update. Interested parties can join via phone or webcast. Nanox aims to transform medical imaging with its innovative digital X-ray technology.
NANO-X IMAGING LTD (NNOX) has partnered with International Clinics Group to enhance medical imaging accessibility in Chile, Bolivia, and Peru. This collaboration aims to deploy the Nanox System, which includes the Nanox.ARC imaging device and Nanox.CLOUD services, across various healthcare facilities, subject to regulatory approval. The initiative addresses the shortage of medical imaging in rural areas, where access is limited. The World Health Organization indicates that two-thirds of the global population lacks adequate imaging services, emphasizing the need for such advancements.
NANO-X IMAGING (NNOX) announced the 8th FDA clearance for its Coronary Artery Calcium solution, enhancing its population health offerings via Zebra Medical Vision. This follows a merger agreement with Zebra aimed at expanding AI-based diagnostic capabilities for chronic conditions. Nanox aims to revolutionize medical imaging with its digital X-ray technology, potentially lowering costs and improving access to early detection services. The company highlights risks linked to acquisitions and regulatory clearances in its forward-looking statements.
Zebra Medical Vision has announced its eighth FDA 510(k) clearance for the HealthCCSng solution, designed to quantify coronary artery calcium (CAC) in existing non-gated CT scans to identify patients at risk for cardiovascular disease. This innovation aims to facilitate early diagnosis and treatment, thereby reducing healthcare costs. Zebra-Med's collaboration with Nanox is expected to enhance its AI capabilities and reach, supporting population health management and preventative care. The company emphasizes its commitment to improving healthcare outcomes through advanced imaging technologies.
Nano-X Imaging Ltd (Nasdaq: NNOX) announces an AI Vision event on October 27, 2021, at 8:30am ET. Hosted by Chairman and CEO Ran Poliakine and Director Erez Meltzer, the event will showcase the integration of AI technologies with Nano-X's imaging solutions, Nanox.ARC and Nanox.SOURCE. This initiative aims to enhance medical imaging systems' affordability and accessibility. The company seeks collaborations with healthcare organizations to provide early detection services. For more details, visit www.nanox.vision.
Nanox, a pioneering medical imaging technology company, announced that its CEO, Ran Poliakine, and Executive Chairman, Erez Meltzer, will present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021, at 9:20 AM ET. A live webcast will be available through the company's website, with a replay accessible afterward. Nanox is focused on revolutionizing medical imaging by developing an affordable digital X-ray source aimed at collaboration with leading healthcare organizations to improve early detection imaging services.
Nanox to Host Business Update Webcast
On August 12, 2021, Nanox, a medical imaging technology company traded under NASDAQ: NNOX, announced a Business Update Video Presentation scheduled for August 16, 2021, at 8:30 am ET. CEO Ran Poliakine and senior leadership will discuss company advancements. Interested participants can register through the provided link. Nanox aims to reduce medical imaging costs with its innovative digital X-ray technology and seeks collaborations for affordable imaging services.